Journal of Neuroscience, Vol 6, 572-580, Copyright © 1986 by Society for Neuroscience
Investigation of the failure of parenterally administered haloperidol to antagonize dopamine released from micropipettes in the caudate
SW Johnson, BJ Hoffer and R Freedman
An anomaly in the experimental data underlying the theory that neuroleptics
act by blockade of dopaminergic neurotransmission is the repeatedly
demonstrated failure in several laboratories of parenterally administered
neuroleptics to antagonize electrophysiologic actions of locally applied
dopamine (DA) in striatum. This failure is enigmatic since many
investigators have successfully demonstrated antagonism when both dopamine
and neuroleptic are applied directly to striatal neurons by
microiontophoresis. We used multibarrel micropipettes to pressure- eject DA
agonists onto rat caudate neurons while observing the ability of
parenterally administered haloperidol to block the inhibitory actions of
dopaminergic agonists on neuronal activity. Experiments performed at times
of maximal behavioural effect of haloperidol did not demonstrate
agonist-antagonist interaction. This result has been obtained by four other
teams of investigators. A variety of pharmacologic manipulations were
employed to help solve this enigma. Acute treatment with reserpine and
alpha-methyl-paratyrosine, performed to minimize any possible interference
by endogenous DA, did not permit blockade of dopamine by haloperidol. To
see if this failure of antagonism could be generalized to other DA
agonists, apomorphine, amphetamine, and phencyclidine (PCP) were also
investigated. Although the direct dopaminergic agonist apomorphine was not
antagonized by haloperidol, the indirect DA agonist PCP was successfully
antagonized. Amphetamine, which has both direct and indirect actions when
applied locally, was not antagonized. Antagonism of direct agonists was
demonstrated in rats with unilateral 6-hydroxydopamine-induced lesions of
the nigrostriatal pathway. In these preparations, parenterally administered
haloperidol reversed the receptor-mediated supersensitivity to the
inhibitory effects of locally applied DA and apomorphine.(ABSTRACT
TRUNCATED AT 250 WORDS)